TRANSTHERA-B (02617) has a current Price-to-Book (P/B) ratio of 69.27. Compared to its 3-year average P/B ratio of 78.95, the current P/B ratio is approximately -12.26% higher. Relative to its 5-year average P/B ratio of 78.95, the current P/B ratio is about -12.26% higher. TRANSTHERA-B (02617) has a Forward Free Cash Flow (FCF) yield of approximately -0.64%. Compared to its 3-year average FCF yield of -0.74%, the current FCF yield is approximately -13.42% lower. Relative to its 5-year average FCF yield of -0.74%, the current FCF yield is about -13.42% lower.

Performance Decomposition

AI Analysis

Market capitalization of 02617 increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of 02617 in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is 02617 currently overvalued or undervalued?

What is TRANSTHERA-B (02617) fair value?

02617's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of TRANSTHERA-B (02617) is between to according to relative valuation method.

How does 02617's valuation metrics compare to the industry average?

The average P/S ratio for 02617's competitors is 0.00, providing a benchmark for relative valuation. TRANSTHERA-B Corp (02617) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for TRANSTHERA-B (02617) as of Mar 03 2026?

As of Mar 03 2026, TRANSTHERA-B (02617) has a P/B ratio of 69.27. This indicates that the market values 02617 at 69.27 times its book value.

What is the current FCF Yield for TRANSTHERA-B (02617) as of Mar 03 2026?

As of Mar 03 2026, TRANSTHERA-B (02617) has a FCF Yield of -0.64%. This means that for every dollar of TRANSTHERA-B's market capitalization, the company generates -0.64 cents in free cash flow.

What is the current Forward P/E ratio for TRANSTHERA-B (02617) as of Mar 03 2026?

As of Mar 03 2026, TRANSTHERA-B (02617) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of TRANSTHERA-B's expected earnings over the next 12 months.

What is the current Forward P/S ratio for TRANSTHERA-B (02617) as of Mar 03 2026?

As of Mar 03 2026, TRANSTHERA-B (02617) has a Forward P/S ratio of 0.00. This means the market is valuing 02617 at $0.00 for every dollar of expected revenue over the next 12 months.

02617 Valuation